Sign in
4

Changes in Ownership

Acumen Pharmaceuticals, Inc. Filed Acc 0001104659-23-083857

Director bought 5,161,290 shares at $7.75 ($39,999,998)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
RA CAPITAL MANAGEMENT, L.P. Director 2023-07-21 Purchase +5,161,290 $7.75 $39,999,998 13,043,179 I
Open-market purchases · 5,161,290 sh · avg $7.75 · $39,999,998
Loading xslF345X05/tm2322012-1_4seq1.xml…